Pub. Date : 2008 Jul
PMID : 18160611
9 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 2 | The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (HUVECs) was investigated using heparin and phospholipase C. The experiment included incubating HUVECs with 0, 1, or 10 U/mL heparin diluted in Dulbecco Modified Eagle"s Medium plus 5% fetal calf serum for 1 or 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 3 | The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (HUVECs) was investigated using heparin and phospholipase C. The experiment included incubating HUVECs with 0, 1, or 10 U/mL heparin diluted in Dulbecco Modified Eagle"s Medium plus 5% fetal calf serum for 1 or 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 4 | The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (HUVECs) was investigated using heparin and phospholipase C. The experiment included incubating HUVECs with 0, 1, or 10 U/mL heparin diluted in Dulbecco Modified Eagle"s Medium plus 5% fetal calf serum for 1 or 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 5 | The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (HUVECs) was investigated using heparin and phospholipase C. The experiment included incubating HUVECs with 0, 1, or 10 U/mL heparin diluted in Dulbecco Modified Eagle"s Medium plus 5% fetal calf serum for 1 or 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 6 | Sequential treatment of HUVECs with phospholipase C and heparin was performed, and a trend was observed where GPI-anchored TFPI levels were increased after 1 hour of pretreatment with heparin but were decreased after 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 7 | Sequential treatment of HUVECs with phospholipase C and heparin was performed, and a trend was observed where GPI-anchored TFPI levels were increased after 1 hour of pretreatment with heparin but were decreased after 24 hours. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 8 | Serum is a requirement for the heparin-dependent release of TFPI from HUVECs. | Heparin | tissue factor pathway inhibitor | Homo sapiens |
| 9 | Heparin pretreatment of HUVECs may affect levels of GPI anchored TFPI in a time and dose-dependent manner. | Heparin | tissue factor pathway inhibitor | Homo sapiens |